Report Detail
Global Targeted Drugs for Multiple Myeloma
- RnM3475098 |
- 30 May, 2019 |
- Global |
- 150 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this study, over the next five years the Targeted Drugs for Multiple Myeloma market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Targeted Drugs for Multiple Myeloma business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Targeted Drugs for Multiple Myeloma market by product type, application, key companies and key regions.
This study considers the Targeted Drugs for Multiple Myeloma value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Immunomodulator
Proteasome Inhibitors
Monoclonal Antibody
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Drug Center
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Celgene
SL Pharma
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
J&J
Takeda
Amgen
Bristol Myers Squibb
Abbvie
Seattle Genetics
Karyopharm Therapeutics
PDL BioPharma
Roche
Sumitomo
Merck
Biogen
Schering-Plough
Glaxo
Chiron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Targeted Drugs for Multiple Myeloma market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Targeted Drugs for Multiple Myeloma market by identifying its various subsegments.
Focuses on the key global Targeted Drugs for Multiple Myeloma players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Targeted Drugs for Multiple Myeloma with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Targeted Drugs for Multiple Myeloma submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Targeted Drugs for Multiple Myeloma Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Targeted Drugs for Multiple Myeloma Market Size 2014-2024
- 2.1.2 Targeted Drugs for Multiple Myeloma Market Size CAGR by Region
- 2.2 Targeted Drugs for Multiple Myeloma Segment by Type
- 2.2.1 Immunomodulator
- 2.2.2 Proteasome Inhibitors
- 2.2.3 Histone Deacetylase Inhibitors (HDACI)
- 2.2.4 Monoclonal Antibody
- 2.2.5 Other
- 2.3 Targeted Drugs for Multiple Myeloma Market Size by Type
- 2.3.1 Global Targeted Drugs for Multiple Myeloma Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Targeted Drugs for Multiple Myeloma Market Size Growth Rate by Type (2014-2019)
- 2.4 Targeted Drugs for Multiple Myeloma Segment by Application
- 2.4.1 Hospital
- 2.4.2 Drug Center
- 2.4.3 Clinic
- 2.4.4 Other
- 2.5 Targeted Drugs for Multiple Myeloma Market Size by Application
- 2.5.1 Global Targeted Drugs for Multiple Myeloma Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Targeted Drugs for Multiple Myeloma Market Size Growth Rate by Application (2014-2019)
3 Global Targeted Drugs for Multiple Myeloma by Players
- 3.1 Global Targeted Drugs for Multiple Myeloma Market Size Market Share by Players
- 3.1.1 Global Targeted Drugs for Multiple Myeloma Market Size by Players (2017-2019)
- 3.1.2 Global Targeted Drugs for Multiple Myeloma Market Size Market Share by Players (2017-2019)
- 3.2 Global Targeted Drugs for Multiple Myeloma Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Targeted Drugs for Multiple Myeloma by Regions
- 4.1 Targeted Drugs for Multiple Myeloma Market Size by Regions
- 4.2 Americas Targeted Drugs for Multiple Myeloma Market Size Growth
- 4.3 APAC Targeted Drugs for Multiple Myeloma Market Size Growth
- 4.4 Europe Targeted Drugs for Multiple Myeloma Market Size Growth
- 4.5 Middle East & Africa Targeted Drugs for Multiple Myeloma Market Size Growth
5 Americas
- 5.1 Americas Targeted Drugs for Multiple Myeloma Market Size by Countries
- 5.2 Americas Targeted Drugs for Multiple Myeloma Market Size by Type
- 5.3 Americas Targeted Drugs for Multiple Myeloma Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Targeted Drugs for Multiple Myeloma Market Size by Countries
- 6.2 APAC Targeted Drugs for Multiple Myeloma Market Size by Type
- 6.3 APAC Targeted Drugs for Multiple Myeloma Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Targeted Drugs for Multiple Myeloma by Countries
- 7.2 Europe Targeted Drugs for Multiple Myeloma Market Size by Type
- 7.3 Europe Targeted Drugs for Multiple Myeloma Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Targeted Drugs for Multiple Myeloma by Countries
- 8.2 Middle East & Africa Targeted Drugs for Multiple Myeloma Market Size by Type
- 8.3 Middle East & Africa Targeted Drugs for Multiple Myeloma Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Targeted Drugs for Multiple Myeloma Market Forecast
- 10.1 Global Targeted Drugs for Multiple Myeloma Market Size Forecast (2019-2024)
- 10.2 Global Targeted Drugs for Multiple Myeloma Forecast by Regions
- 10.2.1 Global Targeted Drugs for Multiple Myeloma Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Targeted Drugs for Multiple Myeloma Forecast by Type
- 10.8 Global Targeted Drugs for Multiple Myeloma Forecast by Application
11 Key Players Analysis
- 11.1 Celgene
- 11.1.1 Company Details
- 11.1.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.1.3 Celgene Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Celgene News
- 11.2 SL Pharma
- 11.2.1 Company Details
- 11.2.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.2.3 SL Pharma Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 SL Pharma News
- 11.3 Natco Pharma
- 11.3.1 Company Details
- 11.3.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.3.3 Natco Pharma Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Natco Pharma News
- 11.4 Intas Pharmaceuticals
- 11.4.1 Company Details
- 11.4.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.4.3 Intas Pharmaceuticals Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Intas Pharmaceuticals News
- 11.5 Indiabulls Pharmaceutical
- 11.5.1 Company Details
- 11.5.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.5.3 Indiabulls Pharmaceutical Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Indiabulls Pharmaceutical News
- 11.6 Cipla
- 11.6.1 Company Details
- 11.6.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.6.3 Cipla Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Cipla News
- 11.7 Glenmark Pharmaceuticals
- 11.7.1 Company Details
- 11.7.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.7.3 Glenmark Pharmaceuticals Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Glenmark Pharmaceuticals News
- 11.8 Dr Reddy's Laboratories
- 11.8.1 Company Details
- 11.8.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.8.3 Dr Reddy's Laboratories Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Dr Reddy's Laboratories News
- 11.9 Qilu Pharmaceutical
- 11.9.1 Company Details
- 11.9.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.9.3 Qilu Pharmaceutical Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Qilu Pharmaceutical News
- 11.10 Chia Tai-Tianqing
- 11.10.1 Company Details
- 11.10.2 Targeted Drugs for Multiple Myeloma Product Offered
- 11.10.3 Chia Tai-Tianqing Targeted Drugs for Multiple Myeloma Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Chia Tai-Tianqing News
- 11.11 Hanson Pharm
- 11.12 Meidakang Huakang Pharmaceutical
- 11.13 Shandong Kongfu Pharmaceutical
- 11.14 J&J
- 11.15 Takeda
- 11.16 Amgen
- 11.17 Bristol Myers Squibb
- 11.18 Abbvie
- 11.19 Seattle Genetics
- 11.20 Karyopharm Therapeutics
- 11.21 PDL BioPharma
- 11.22 Roche
- 11.23 Sumitomo
- 11.24 Merck
- 11.25 Biogen
- 11.26 Schering-Plough
- 11.27 Glaxo
- 11.28 Chiron
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Targeted Drugs for Multiple Myeloma . Industry analysis & Market Report on Targeted Drugs for Multiple Myeloma is a syndicated market report, published as Global Targeted Drugs for Multiple Myeloma . It is complete Research Study and Industry Analysis of Targeted Drugs for Multiple Myeloma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
